Global Intravenous Solutions (Colloids) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Intravenous Solutions (Colloids) market size will reach 14,460 Million USD in 2025 and is projected to reach 22,338 Million USD by 2032, with a CAGR of 6.41% (2025-2032). Notably, the China Intravenous Solutions (Colloids) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Intravenous solutions containing colloids are sterile liquid preparations administered directly into the veins for therapeutic purposes. Unlike crystalloid solutions, which primarily consist of electrolytes and water, colloids contain larger particles, often in the form of proteins or synthetic substances, that remain suspended in the solution. These colloidal solutions are used to address conditions where there is a need to increase the oncotic pressure within the blood vessels or to support plasma volume expansion. Albumin and synthetic colloids like hydroxyethyl starch are examples of colloidal solutions frequently used in intravenous therapy. Colloids help to retain fluid within the blood vessels and can be employed in situations such as hypovolemic shock, severe burns, or major surgeries where maintaining adequate intravascular volume is crucial. The use of intravenous colloids requires careful consideration of the patient's medical condition, and their administration is typically under medical supervision to ensure appropriate dosage and monitoring for potential side effects.

The major global  manufacturers of Intravenous Solutions (Colloids) include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, Amanta Healthcare, Grifols S.A., Terumo Medical Corporation, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Intravenous Solutions (Colloids). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravenous Solutions (Colloids) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Intravenous Solutions (Colloids) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravenous Solutions (Colloids) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Intravenous Solutions (Colloids) Include:

ICU Medical Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Baxter

Amanta Healthcare

Grifols S.A.

Terumo Medical Corporation

Intravenous Solutions (Colloids) Product Segment Include:

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Intravenous Solutions (Colloids) Product Application Include:

Hospital and Clinics

Ambulatory

Home Care

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Intravenous Solutions (Colloids) Industry PESTEL Analysis

Chapter 3: Global Intravenous Solutions (Colloids) Industry Porter's Five Forces Analysis

Chapter 4: Global Intravenous Solutions (Colloids) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 5: Global Intravenous Solutions (Colloids) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 6: Global Intravenous Solutions (Colloids) Sales, Revenue, Price and Forecast by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 8: Industrial Chain Analysis, Intravenous Solutions (Colloids) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources